Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study.
about
Proton therapy for early stage prostate cancer: is there a case?A dosimetric analysis of volumetric-modulated arc radiotherapy with jaw width restriction vs 7 field intensity-modulated radiotherapy for definitive treatment of cervical cancer.Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer.Normal tissue studies in radiation oncology: A systematic review of highly cited articles and citation patterns.Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06.Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman modelTransitioning from conventional radiotherapy to intensity-modulated radiotherapy for localized prostate cancer: changing focus from rectal bleeding to detailed quality of life analysisResults and DVH analysis of late rectal bleeding in patients treated with 3D-CRT or IMRT for localized prostate cancerPrediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues.Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer.Physics aspects of prostate tomotherapy: planning optimization and image-guidance issues.Gastrointestinal toxicity associated to radiation therapy.Proton beam radiation therapy for prostate cancer-is the hype (and the cost) justified?Reducing rectal injury during external beam radiotherapy for prostate cancer.The evolution of rectal and urinary toxicity and immune response in prostate cancer patients treated with two three-dimensional conformal radiotherapy techniques.Voxel-based population analysis for correlating local dose and rectal toxicity in prostate cancer radiotherapy.Clinical implementation of a knowledge based planning tool for prostate VMAT.Accumulated dose to the rectum, measured using dose-volume histograms and dose-surface maps, is different from planned dose in all patients treated with radiotherapy for prostate cancerDefecation into clothing without forewarning and mean radiation dose to bowel and anal-sphincter among gynecological cancer survivors.Reducing rectal injury in men receiving prostate cancer radiation therapy: current perspectives.Clinical and dosimetric predictors of late rectal bleeding of prostate cancer after TomoTherapy intensity modulated radiation therapy.Intensity-modulated radiation therapy from 70Gy to 80Gy in prostate cancer: six- year outcomes and predictors of late toxicity.Self-assessed bowel toxicity after external beam radiotherapy for prostate cancer--predictive factors on irritative symptoms, incontinence and rectal bleeding.Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trialLate rectal and bladder toxicity following radiation therapy for prostate cancer: Predictive factors and treatment results.Spatial rectal dose/volume metrics predict patient-reported gastro-intestinal symptoms after radiotherapy for prostate cancer.Salvage intensity modulated radiotherapy using endorectal balloon after radical prostatectomy: clinical outcomes.Prostate and seminal vesicle volume based consideration of prostate cancer patients for treatment with 3D-conformal or intensity-modulated radiation therapy.Factors Predicting Late Rectal Disorders after Radiation Therapy for Prostate Cancer.Effectiveness of sacral nerve stimulation in fecal incontinence after multimodal oncologic treatment for pelvic malignancies: a multicenter study with 2-year follow-up.Acute and late complications after hypofractionated intensity modulated radiotherapy in prostate cancer.Impact of changing rectal dose volume parameters over time on late rectal and urinary toxicity after high-dose intensity-modulated radiotherapy for prostate cancer: A 10-years single centre experience.Dose-volume factors to select patient-specific image-guidance action thresholds in prostate cancer.Using Bayesian logistic regression to evaluate a new type of dosimetric constraint for prostate radiotherapy treatment planning.Proton Beam Therapy Alone for Intermediate- or High-Risk Prostate Cancer: An Institutional Prospective Cohort Study.Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?Image-guided dose-escalated intensity-modulated radiation therapy for prostate cancer: treating to doses beyond 78 Gy.Association between rectal bleeding and the absolute dose volume of the rectum following image-guided radiotherapy for patients with prostate cancer.Association between EBRT dose volume histograms and quality of life in prostate cancer patients
P2860
Q28072657-BA65DD1B-B578-49F3-B252-D419D3328B34Q33823328-AA173231-E963-4BF4-A8E5-FE06A86ACA1EQ33919002-B3B805EB-0938-4FF9-9C0F-879A9C5504B9Q33967649-49F2646A-3791-4AE8-80FA-D56ED784FFE2Q34161145-83DAF01F-DB13-4800-9F2D-19724044D160Q34238364-DE657DE8-C696-4F9D-AF28-8C3B852DE990Q34500966-5BE79071-6182-44D7-AD1F-BCBD1D922015Q35248634-E647BB37-035D-403D-BA45-A17977BEDB79Q35500065-7E1CC596-D706-41F8-AAAD-ABB8D99B7478Q36202855-AB9C71BC-0817-4AEE-A3A6-91C1EB6FF09EQ37139334-4FAA9D29-E629-4215-8559-30E7D6D0D26EQ37237456-EBCC8DF7-0AA1-4DC1-BB79-137344FC5A3DQ37780019-50EB4E9C-E0B4-4230-9783-CD4A11A35BA1Q38095001-18E2A1A8-50A9-4E5C-BBDF-8F5422608945Q38106626-3DBFEF50-C647-468E-8484-B35EFA663963Q38266168-4FD6023B-CCE0-4BA9-8974-1AE18A621143Q38721165-0AB83041-7498-407D-AE47-8F1D2AD191CAQ38797630-054CD3C9-26FD-426A-BEBA-895CC7C5E71EQ38981805-3E22A400-A186-4DB6-8D5D-C0DE317DF8BCQ39770740-7EDD34DA-7271-497F-A57A-7329C291053DQ41276603-752742C6-10A9-48E6-B662-E2B46FA67A87Q41633588-3FA988D5-7680-4A07-8247-15AA058E91BCQ42199585-81F7F7A0-5A11-454F-A966-E87E9537204DQ42571229-8D93E85D-346F-48BB-BCD4-A99D8B3121DBQ42571904-8215653E-08EC-4E46-933D-53CEFF8E979CQ42794419-C6671421-4D6F-49D7-BE89-FDAB8D7299FAQ43365011-A661D94B-D1EC-4AF7-88E5-FE3E509D96C3Q44220551-8683BE5A-2971-40AF-AB33-D77F225CB2D7Q45936840-EF768026-EED2-45A8-A88A-8CB6BFF34347Q47141907-9317DC7A-1224-4467-B8AD-48CDF04E542BQ47192857-6240AF76-A312-47E0-9F81-822299D60AADQ48141226-52427AFB-D1A7-47B4-A4E2-49EE43AB7CE7Q49037031-ECA98037-C9D7-487D-A637-0A16E0F0824BQ50682681-8AAF6AB5-0B7A-400F-9305-66C8125849CFQ51699959-04A85F58-C671-45DD-ABAC-0D07F381F5BAQ52593552-9C3103CC-5F9F-4BA2-9DB1-E070F9C376BBQ52958760-A030A820-E3BB-4FC5-B448-7BE899673704Q53143050-4D367135-0B28-493C-83D5-BDAB261120C9Q55663443-80EC27FA-F352-46BE-8BA0-A2FCE262CBF9Q57166124-917CFDE3-921E-4BFC-BF58-1BE76850351D
P2860
Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Clinical and dosimetric predic ...... multicenter prospective study.
@en
Clinical and dosimetric predic ...... multicenter prospective study.
@nl
type
label
Clinical and dosimetric predic ...... multicenter prospective study.
@en
Clinical and dosimetric predic ...... multicenter prospective study.
@nl
prefLabel
Clinical and dosimetric predic ...... multicenter prospective study.
@en
Clinical and dosimetric predic ...... multicenter prospective study.
@nl
P2093
P50
P1476
Clinical and dosimetric predic ...... multicenter prospective study
@en
P2093
Carla Bianchi
Gianni Fellin
Giuseppe Girelli
Loris Menegotti
Marco Mapelli
Simona Nava
Valeria Casanova Borca
Vittorio Vavassori
P304
P356
10.1016/J.IJROBP.2007.07.2354
P407
P577
2007-09-19T00:00:00Z